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Protein gene product 9.5 (PGP 9.5), which in the normal nervous system is restricted to certain neurons, has been detected in two glioma cell lines, 
rat C6 and human GLIS, by immunoblotting and immunocytochemistry. Its expression in thcsc cells depends on the cellular growth state, being 
maximal between the first and second post-plating day. Only a faint PGP 9.5 immunoreactivity can be observed in glioma sells after the eleventh 
post-plating day, i.e. about one week after confluency has been reached. The present results suggest hat PGP 9.5 in cultured glial cells is maximally 
expressed during the growth phase and that the protein could play a role during brain development in glial cells, in reactive gliosis, or in 
tumorigenesis of the glial lineage. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Protein gene product 9.5 (PGP 9.5) is a 26 kDa acidic 
protein originally purified from human brain [I] and 
shown to be a marker of certain neurons in the central 
nervous system [l]. Subsequent studies demonstrated 
that this protein is also found in axons in the peripheral 
nervous system [2-61, in a variety of neuroendocrine 
cells [2,7], in adrenal medulla [g], in human skin cells [5], 
and in neuroectodermal tumors [9,10]. The analysis of 
the primary structure of PGP 9.5 and of its cDNA [I 1] 
revealed that this protein is highly homologous to ubi- 
quitin carboxyl-hydrolase isozymes [12], and that calf 
brain PGP 9.5 has ubiquitin carboxyl-terminal hy- 
droxylase activity [12], suggesting that PGP 9.5 might 
be a member of a multigene family of related isozymes. 
The mammalian brain is by far the richest source of 
PGP 9.5 [13]. No evidence for the presence of PGP 9.5 
in glial cells in the nervous tissue has been presented 
thus far by either light [1] or electron [4] immunocyto- 
chemistry. 
2.1. PurtJimlion of PGP 9.5 
All operations were done at 4°C. Frozen bovine brain tissue (350 
g) was homogenized in 5 vols. of buffer A IO mM Tris-HCI, pH 7.5, 
5 mM 2-mercaptoethanol, I mM EDTA) and centrifuged at 13 000 x 
g for 1 h. The supernatant was brought stepwisc to 100% saturation 
with solid (NH&SO4 [14]. Proteins which precipitated between 80 and 
100% saturation with (NH&SO., were resuspended in 60 ml of buffer 
A and dialyzed against 5 I of buffer A for I .5 days with 3 changes of 
the dialysis buffer. The dialysate was loaded onto a column of DEAE 
Sephacel (cm 1.5 x 30) equilibrated with buffer A. The column was 
washed with 250 ml of buffer A and developed with a nine-chamber 
gradient of NaCl and pH [l5]. Fractions of 7.5 ml were collected. The 
protein peak corresponding to fractions 62-70 was concentrated and 
loaded onto a column of Sephacryl S-200 (cm 2 x 90) equilibrated with 
buffer A for final purification of PGP 9.5. See section 3 for further 
details. 
2.2. Itrtrnut~ocl~ett~icul m yses 
We show here that 2 glioma cell lines, rat C6 and 
human GLl5, express PGP 9.5 and that the expression 
of PGP 9.5 in these glioma cells depends on the cellular 
growth state. 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS- 
PAGE) (10% acrylamide) was done as in [16]. Gels were stained with 
Coomassie blue. Electrophoretically pure PGP 9.5 was used to raise 
antisera in rabbits by multisite injections exactly as in [17]. The speci- 
ficity of antisera was assessed by immunoblotting by the method in 
[If% 
2.3. Itrtmunocytochett~ical nalyses 
C6 or GLl5 [19] glioma cells plated on glass coverslips in tissues 
culture cluster plates at a cell density of 5 x 1 O4 cells/well were cultured 
in DMEM supplemented with 20% heat-inactivated calf serum and 
100 iu penicillin and 0.1 mg streptomycin/ml. The culture medium was 
changed every other day. At intervals, ceils were washed free of the 
culture medium with 20 mM Tris-HCI, pN 7.5,0.9% (w/v) NaCl (TBS) 
and fixed with 4% (w/v) paraformaldehyde in TBS for 20 min at room 
temperature. After several washings with TBS, cells were permeabil- 
ized with 0, I % (v/v) Triton X-100 in TBS for 30 min at room tempera- 
ture, and washed with TBS. Before immunocytochemistry, fixed cells 
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Fig. 1. Purification of bovine brain PGP 9.5. DEAE Sephacryl chrom- 
atography of proteins that precipitated between 80 and 100% satura- 
tion with (NH&SO,. The column was developed with a nine-chamber 
gradient of NaCl and pW [15]. Fractions 62-70 (underlined) contained 
a 26 kDa polypeptide in large amounts plus a -70 kDa contaminant, 
as investigated by SDS-PAGE (inset). 
were treated with 3% (v/v) I1,Oz ir! methanol for I5 min at room 
temperature to b!ock any endogenous peroxidase activity, and washed 
extensively with TBS. Cells were then incubated with 3% (w/v) boi;ine 
serum albumin (BSA) in TBS for 3 h at room temperature, followed 
by the rabbit anti-PGP 9.5 antiserum (150 in I% BSA in TBS) at 4°C 
overnight. This step was followed by sequential incubations of cells 
with a sheep-anti-rabbit IgG antiserum (I :40 in 1% BSA in TBS) and 
with a rabbit peroxidase-anti-peroxidase complex (I:100 in 1% BSA 
in TBS), each for I h at room temperature. Washing of cells after each 
step was done with 0.1% Triton X-100 in TBS (twice for 5 min) 
followed by TBS (twice for 5 min). Cells were finally incubated with 
0.3 mg ofdiaminebenzidine/mI of 50 mM Tris-HCI, pH 7.5,containing 
0.02% Hz02, in the dark for 20 min. Cells were washed with TBS and 
mounted in permanent aqueous mounting medium on glass slides for 
light microscopy. In control experiments, the anti-PGP 9.5 anti-serum 
was omitted, replaced by the pre-immune antiserum, or substituted for 
by anti-PGP 9.5 antiserum previously absorbed with PGP9.5. Identi- 
cal results were obtained irrespective of the procedure used, i.e. no 
immune reaction product could be seen (not shown). 
3. RESULTS AND DISCUSSION 
By DEAE chromatography of brain proteins that 
precipitated between 80 and 100% saturation with 
(NH&S04, several protein peaks could be resolved 
(Fig. 1). The protein peak corresponding to fractions 
62-70 contained a 26 kDa polypeptide in large amounts 
plus a contaminant of -70 kDa (Fig. 1, inset), as investi- 
gated by SDS-PAGE. This protein peak was con- 
centrated and chromatographed on Sephacryl S-200. 
Two major protein peaks were obtained (Fig. 2A), the 
second of which contained the 26 kDa polypeptide in 
pure form (Fig. 2B). The chromatographic behavior of 
the 26 kDa polypeptide indicated that the purified poly- 
peptide was a monomeric protein. An antiserum raised 
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Fig. 2. Purification of bovine brain PGP 9.5. (A) Sephacryl S-200 
chromatography of fractions 62-70 from the DEAE Sephacel chrom- 
atography illustrated in Fig. 1. The major protein peak contained the 
26 kDa polypeptide in pure form. (E) SDS-PAGE of fraction No. 76 
of the chromatogram in (A). In those cases where still-contaminated 26 
kDa protein was recovered after chromatography on Sephacryl S-200, 
final purification was accomplished by chromatography of the major 
protein peak in (A) on DEAE Sephacel (cm 1 x 5) in buffer A with 
elution by means of a O-O.25 M gradient of NaCl in buffer A (not 
shown), 
against the 26 kDa protein proved specific to this 
protein by immunoblotting (Fig. 3). This antiserum de- 
corated cell bodies and the dendritic tree of Purkinje 
cells in rat cerebellum and no other elements in the 
cerebellar cortex [20], axons in the cerebellar white 
matter (not shown), and rat cerebellar Purkinje cells and 
1 2 3 4 
Fig. 3. Immunochemicalcharacterization f PGP 9.5. Rat brain PGP 
9.5 (lane I), bovine brain PGP 9.5 (lane 2), SDS-extracts from GLI 5 
(lane 3) and C6 (lane 4) glioma cells were subjected to SDS-PAGE and 
electroblotted onto nitrocellulose paper for immunostaining with the 
anti-26 kDa (PGP 9.5) antiserum (I:lOOO). The arrow points to the 
position of PGP 9.5. Note that the anliserum is specific to the protein. 
CL15 or C6 glioma cells grown on 35mm plastic petri dishes (2 x IO5 
ccllsldish) were cultivated for 2 days, washed free of the culture me- 
dium with TBS, and extracted with 0.2 ml of 3% SDS in 50 mM 
Tris-HCI, pH 7.5, for 15 min at room temperature. 2-Mercaptoethanol 
was rhcn added to a finalconcentration of 5% before boiling for 5 min 
and electrophoresis. 
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2fi kDa proteiu MET GLN 1.W I.YS PRO MET CLU IS0 ASP I’& GLU 
r%f 9.5 
26 kDa protein MET LEU ASN LYS VAL LEU THR ARG Lg8 GLY VAL - ___ 
POP 9.5 NET LEU ASN LYS VAL LEU SER ARC VAI. GLY VAL - - 
28 kDa protein ALA GLY GLN 
PCP 9.5 ALA GLY CLN 
Fig. 4. Partial amino acid sequence analysis of the purified 26 kDa 
protein. Comparison with the amino acid sequense of PGP 9.5 [I 11. 
Aside from a leader sequence of eleven residues, the 26 kDa protein 
is 86Y0 homologous, in the sequenced portion, to PGP 9.5. The two 
substitutions are conservative. Identical residues are underlined. 
nxons in rat sciatic nerves by immunocytochemistry at 
the electron microscope level [4]. 
Partial amino acid sequence analysis of electro- 
phoretically pure 26 kDa protein (done in the labo- 
ratory of Professor Robert H. Kretsinger, Charlot- 
tesville, VA) revealed that, aside from a leader sequence 
of 11 residues, the next 14 residues of the protein were 
86% identical to the corresponding sequence of human 
brain PGP 9.5 [ll], with 2 conservative substitutions 
(Fig. 4). 
Three lines of evidence suggested that our 26 kDa 
Fig. 5. lmmunocytochemical localization of PGP 9.5 in rat C6 glioma 
cells. At low magnification (x90), C6 cells appeared as spindle-shaped 
cells displaying immunoreactivity in the cytoplasm of cell bodies and 
processes. At a higher magnification (x900) (inset) the PGP 9.5 immu- 
noreactivity is clearly seen in the cytoplasm. 
protein was the bovine brain form of human PGP 9.5: 
(i) both proteins were acidis, precipitated between 80 
and 100% saturation with (NH&X&, and had an M, 
of -26 kDa; (ii) a high sequence homo!ogj; -was observed 
between the portion of our 26 kBa protein so far se- 
quenced and PGP 9.5; and (iii) an antiserum raised 
against the bovine brain 26 kDa protein decorated cere- 
Fig. 6. Immunocyto~hemical localization of PGP 9.5 in human GL15 glioma cells as a function of cellular growth state. At day 1 after plating (A) 
both cell types constrtuting this cell line were immunostained. Generally, the spindle-shaped cells dispiayed a more intense immunoreactivity than 
the large and flat ones. Under the present experimental conditions, cells attained confluency between the second (B) and fourth (C) post-plating 
day. By this time most of cells were spindle-shaped and the immunostaining per cell appeared to decrease. At days 7 (D) and 11 (E) after plating, 
only a faint immunoreactivity was seen, and an even fainter immunostaining was observed at the eighteenth post-plating day (F). The inset in (F) 
shows a dividing cell at me&phase displaying an intense immune reaction product in the cytoplasm, excepting the region of metaphase chromoso- 
mes. Less intense immunoreactivity seems to be present in the regions of spindle poles. Original magnifications: A-E = x 160; F = x90; F (inset) 
= x400. 
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bellar Purkinje cells and axons in the cerebellum and 
peripheral nerves. 
Yet, in spite of the well-documented absence of PGP 
9.5 from glial cells in the central and peripheral nervous 
system of adult mammals, as mentioned above, by im- 
munoblotting we detected PGP 9.5 in two gliorna cell 
lines, human GL15 and rat C6 (Fig. 3, lanes 3 and 4, 
respectively). By immunocytochemistry, in rat C6 
glioma cells, the protein was found diffusely in the cy- 
toplasm of cell bodies and processes (Fig. 5). A similar 
localization of PGP 9.5 was observed in human GL1.5 
glioma cells (Fig. 6A). This cell line comprises 2 mor- 
phologically distinct cell types, one spindle-shaped and 
one flat and large [19]. Both cell types derive from the 
same parental cell and display the same chromosomal 
abnormalities [19]. Generally, the spindle-shaped cells 
appeared more intensely immunostained than the flat 
and large cells. Following this observation, we investi- 
gated the expression of PGP 9.5 in the two cell lines as 
a function of celluIar growth state. Identical results were 
obtained with either cell line. Specifically, in both C6 
cells (not shown) and GL15 cells (Fig. 6 A-F) the max- 
imum of immunostaining/cell was observed between the 
first and second post-plating day (Fig. 6A,B) under our 
cu!ture cnnrl;t;nnr At the ebwn,tk, pcst_p!a’,ir,g &y, i.e. “IIY.I.“.Z”. ‘ I). L.ZW W.YI”I 
about one week after confluency (Fig. 6E), most of cells 
appeared spindle-shaped and only a faint immunostain- 
ing was detected. An even fainter immunostaining was 
seen at the eighteenth post-plating day (Fig. 6F). Thus, 
it appears that the maximum of expression of PGP 9.5 
in glioma cells coincides with the maximum of replica- 
tion, whereas as confluency is attained, the expression 
of the protein progressively declines. Whether the 
decreased PGP 9.5 immune reaction product in post- 
confluent glioma cells depends on decrease in its synthe- 
sis and/or increase in its degradation will be a matter for 
future research. Also the mRNA levels of PGP 9.5 will 
be investigated under the same experimental conditions. 
That replicating glioma cells express large amounts of 
PGP 9.5 is also documented in Fig. 6F (inset) where a 
dividing cell is shown. With the exception of metaphase 
chromosomes, the rest of the cell displays an intense 
immune reaction product. By the present experimental 
approach it was not possible to ascertain whether PGP 
9.5 immunoreactivity is also present on elements of the 
mitotic spindle. Immunocytochemistry at the electron 
microscope level will hopefully elucidate this point. 
While this manuscript was in preparation, localiza- 
tion of PGP 9.5 in cultured human MIX-5 fibroblasts 
of normal origin was reported [21]. Also, PGP 9.5 was 
shown to be strongly down-regulated in the SV40-trans- 
formed counterparts of these cells [2 11, These data were 
interpreted as suggesting that culturing of fibroblasts 
might have induced the expression of PGP 9.5 in these 
cells, since fibroblasts in their normal environment in 
vivo do not express the protein, Similarly, it is possible 
that culturing might have induced the expression of 
PGP 9.5 in a cell type, the glial cell, which does not 
express the protein in the nervous tissue. Significantly, 
the maximum of expression of the protein in glioma 
cells was observed during the proliferation phase, sug- 
gesting that PGP 9.5 might be involved in the regulation 
of as yet unknown activities in these cells during the 
growth phase. lmmunochemical and immunocytoche- 
mica1 analyses of PGP 9.5 during development of the 
nervous system would shed light on the pattern of ex- 
pression of this protein in nervous cells, as well as on 
the possible biological role(s) of this protein. As a 
member of a family of enzymes with ubiquitin carboxyl- 
terminal hydroxylase activity [12], PGP 9.5 could play 
an important role during proliferation of glial cells in 
the nervous system, during reactive gliosis, and/or in 
connection with tumorigenesis of the glial lineage. 
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